Understanding how m6A modifications in RNA affect cell functions and development
Mechanisms of Regulation of the m6A mRNA Methylation Machinery
This study is looking at how a specific change in RNA, called m6A, affects how our genes work and how cells grow and develop, which could help us understand diseases better and find new ways to treat them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10874640 on NIH RePORTER |
What this research studies
This research investigates the role of N6-methyladenosine (m6A), a common modification in RNA, in regulating gene expression and cellular functions. By examining how m6A influences processes like cell proliferation and differentiation, the study aims to uncover the mechanisms that control RNA metabolism in response to various signals. Patients may benefit from insights gained about how these processes are linked to diseases, potentially leading to new therapeutic strategies. The research employs advanced techniques to analyze the interactions and regulatory pathways involved in m6A modification.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions related to cell proliferation and differentiation, such as certain cancers or developmental disorders.
Not a fit: Patients with conditions unrelated to RNA metabolism or cellular regulation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases linked to RNA regulation and cellular dysfunction.
How similar studies have performed: Other research has shown promising results in understanding RNA modifications and their implications in various diseases, indicating that this area of study is both relevant and potentially impactful.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Alarcon, Claudio R — Yale University
- Study coordinator: Alarcon, Claudio R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.